These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27526171)

  • 1. MMP-14 Triggered Fluorescence Contrast Agent.
    Nguyen MD; Kang KA
    Adv Exp Med Biol; 2016; 923():413-419. PubMed ID: 27526171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditionally activating optical contrast agent with enhanced sensitivity via gold nanoparticle plasmon energy transfer: feasibility study.
    Kang KA; Wang J
    J Nanobiotechnology; 2014 Dec; 12():56. PubMed ID: 25481683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanoparticle-Based Fluorescent Contrast Agent with Enhanced Sensitivity.
    Kang KA; Nguyen MD
    Adv Exp Med Biol; 2017; 977():399-407. PubMed ID: 28685471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticle-fluorophore complex for conditionally fluorescing signal mediator.
    Wang J; Achilefu S; Nantz M; Kang KA
    Anal Chim Acta; 2011 Jun; 695(1-2):96-104. PubMed ID: 21601036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of proteolytic activity in metastatic cancer cells using fluorogenic gold nanoprobes.
    Hong Y; Ku M; Heo D; Hwang S; Lee E; Park J; Choi J; Lee HJ; Seo M; Lee EJ; Yook JI; Haam S; Huh YM; Yoon DS; Suh JS; Yang J
    Biosens Bioelectron; 2014 Jul; 57():171-8. PubMed ID: 24583688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly specific, NIR fluorescent contrast agent with emission controlled by gold nanoparticle.
    Wang J; O'Toole M; Massey A; Biswas S; Nantz M; Achilefu S; Kang KA
    Adv Exp Med Biol; 2011; 701():149-54. PubMed ID: 21445782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorophore-gold nanoparticle complex for sensitive optical biosensing and imaging.
    Wang J; Moore J; Laulhe S; Nantz M; Achilefu S; Kang KA
    Nanotechnology; 2012 Mar; 23(9):095501. PubMed ID: 22327387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRET-like fluorophore-nanoparticle complex for highly specific cancer localization.
    Wang J; Nantz MH; Achilefu S; Kang KA
    Adv Exp Med Biol; 2010; 662():407-13. PubMed ID: 20204823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIR fluorophore-hollow gold nanosphere complex for cancer enzyme-triggered detection and hyperthermia.
    Wang J; Wheeler D; Zhang JZ; Achilefu S; Kang KA
    Adv Exp Med Biol; 2013; 765():323-328. PubMed ID: 22879051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence manipulation by gold nanoparticles: from complete quenching to extensive enhancement.
    Kang KA; Wang J; Jasinski JB; Achilefu S
    J Nanobiotechnology; 2011 May; 9():16. PubMed ID: 21569249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo sensing of proteolytic activity with an NSET-based NIR fluorogenic nanosensor.
    Ku M; Hong Y; Heo D; Lee E; Hwang S; Suh JS; Yang J
    Biosens Bioelectron; 2016 Mar; 77():471-7. PubMed ID: 26454829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent Indicator Displacement Assay: Ultrasensitive Detection of Glutathione and Selective Cancer Cell Imaging.
    Das K; Sarkar S; Das PK
    ACS Appl Mater Interfaces; 2016 Oct; 8(39):25691-25701. PubMed ID: 27618963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP.
    Lin Y; Chang G; Wang J; Jin W; Wang L; Li H; Ma L; Li Q; Pang T
    Exp Cell Res; 2011 Aug; 317(14):2031-40. PubMed ID: 21669197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFκB/c-Jun activation in breast cancer MDA-MB-231 cells.
    Chen YJ; Lee YC; Huang CH; Chang LS
    Toxicol Appl Pharmacol; 2016 Nov; 310():98-107. PubMed ID: 27634460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
    Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
    J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized surface plasmon resonance based nanobiosensor for biomarker detection of invasive cancer cells.
    Hong Y; Ku M; Lee E; Suh JS; Huh YM; Yoon DS; Yang J
    J Biomed Opt; 2014 May; 19(5):051202. PubMed ID: 24297057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells.
    Augustin S; Berard M; Kellaf S; Peyri N; Fauvel-Lafève F; Legrand C; He L; Crépin M
    Anticancer Res; 2009 Apr; 29(4):1335-43. PubMed ID: 19414384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection.
    Shimizu Y; Temma T; Sano K; Ono M; Saji H
    Cancer Sci; 2011 Oct; 102(10):1897-903. PubMed ID: 21718387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantum dots based molecular beacons for in vitro and in vivo detection of MMP-2 on tumor.
    Li X; Deng D; Xue J; Qu L; Achilefu S; Gu Y
    Biosens Bioelectron; 2014 Nov; 61():512-8. PubMed ID: 24951921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.